Introducing Dr. Manel Esteller, Editor-in-Chief, Epigenetics
Dr. Manel Esteller graduated in Medicine from the University of Barcelona, where he also obtained his Ph.D. degree specialising in cancer molecular genetics. He is the Director of the Josep Carreras Leukaemia Research Institute (IJC), Chairman of Genetics in the School of Medicine of the University of Barcelona, and an ICREA Research Professor, as well as the Editor-in-Chief of Epigenetics.
His current research is devoted to the establishment of the epigenome and epitranscriptome maps of normal and transformed cells, the study of the interactions between epigenetic modifications and non-coding RNAs, and the development of new epigenetic drugs for cancer therapy.
Author of more than 600 original publications in peer-reviewed scientific journals, 24 of them categorized as “Highly Cited Paper”, Dr. Esteller is considered among the Top 0.01% of World Scientists based on Impact by both the Stanford University (METRICS) and the Web of Science Group-Clarivate Analytics. In 2021 he was been elected as Member of the Academia Europaea and of the European Academy of Sciences.
Join us for a Twitter interview: #DrEstellerChatsOA
From 2023, Epigenetics is converting to a fully open access journal (having operated under a hybrid model previously). We will be chatting to Dr. Esteller via Twitter (@Tandfbiosci) on 23 September at 9am (BST) to discuss this move, the journal, and why open access research is so important to the field. Follow along or join in the discussion using the hashtag: #DrEstellerChatsOA